InnovAge
INNV
#6633
Rank
ยฃ0.52 B
Marketcap
ยฃ3.85
Share price
1.98%
Change (1 day)
1.85%
Change (1 year)

Revenue for InnovAge (INNV)

Revenue in 2025 (TTM): ยฃ0.67 Billion

According to InnovAge's latest financial reports the company's current revenue (TTM ) is ยฃ0.66 Billion. In 2024 the company made a revenue of ยฃ0.64 Billion an increase over the revenue in the year 2023 that were of ยฃ0.56 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for InnovAge from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.67 B4.59%
2024 ยฃ0.64 B13.61%
2023 ยฃ0.56 B-0.64%
2022 ยฃ0.56 B13.65%
2021 ยฃ0.50 B12.49%
2020 ยฃ0.44 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AcelRx Pharmaceuticals
ACRX
ยฃ0.48 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
ยฃ2.72 B 311.95%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Cocrystal Pharma
COCP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.01 B 7,160.96%๐Ÿ‡บ๐Ÿ‡ธ USA